Business
OpenAI o1 is a new series of AI models designed to spend more time thinking before they respond.
Hi, what are you looking for?
The researchers: “Just as today many of us possess objects of Jewish significance, so did the lamp’s owner, some 200 years after the Temple’s...
Innovative bio-convergence lab to propel Israel as a global leader in smart medical diagnostics, environmental restoration, and sustainable energy generation
Historically, cancer treatment focused on directly destroying malignant cells through methods like radiation and chemotherapy.
OpenAI o1 is a new series of AI models designed to spend more time thinking before they respond.
Israel High Tech Scene September 7 – September 13 New Startups / VC Funding Breakthrough Treatment for Degenerative Disc Disease: Israeli MedTech Startup Discure...
“Once a world of rivers, lakes, and possibly oceans, Mars now reveals its secrets through chloride salt deposits found by our ExoMars Trace Gas...
In other words, Jared Isaacman went where no private citizen has gone before.
The Discure System is a minimally invasive, implantable bioelectronic device designed to treat and potentially reverse the progression of DDD.
Melatonin is a hormone naturally produced by the body's pineal gland in response to darkness.
Datricks provides a quick and affordable solution to deliver comprehensive financial and compliance reporting to the external auditor.
Researchers have developed a new approach that induces an increase in T-cell proliferation while maintaining or even enhancing the cells’ killing prowess.
The firm raised $50 million in a Series A investment round led by Eclipse, bringing its total funding to date to $77 million.
IVC's analysis indicates that Israeli venture capital funds had approximately $10.2 billion in unallocated capital as of August 2024.